MBX Capital — 2026 Investments
4 investments dated 2026 · listed companies and verified rows first · show all
Contraline develops new contraceptive and reproductive health technologies, with a focus on male contraception.
BiotechDigital HealthMedical DevicesCharlottesville, US
Kevin S Eisenfrats(Executive Officer, Director, Promoter)Kevin Eisenfrats(Co-Founder and CEO)John Herr(Co-Founder)
BoardIris Van Alderwerelt van Rosenburgh(Director)Martin J Emerson(Director)
Board seatGurdane Bhutani· per SEC Form D
Co-investorsBiotechnology Value FundAllied Venture PartnersAmboy Street VenturesAurum Venture PartnersBeni Venture CapitalCleo Capital+14 more
Junction Health partners with Federally Qualified Health Centers (FQHCs) to set up and manage IV infusion therapy sites, expanding access to infusion services for chronically ill, uninsured, Medicaid, and underserved patients across the US.
Digital HealthHealthtechImpact & Social GoodMedical DevicesDenver, US
Ben Wiederholt(Co-founder & CEO)Vinny Polito(Co-founder & COO)Matt Vestal(Co-founder & Chief Commercial Officer)Vincent Joseph Polito(Executive Officer, Director)Matthew Adam Vestal(Executive Officer, Director)Ben Richard Wiederholt(Executive Officer, Director)
Board seatGurdane Bhutani· per SEC Form D
BiotechGreenwood Village, US
Rajeev Kumar(Executive Officer, Director)
Board seatGurdane Bhutani· per SEC Form D · $6.5M raise · filed Jul 2026
Keebler Health, founded in 2023, is a healthcare company focused on improving efficiency and efficacy in the healthcare industry.
AI & Machine LearningDigital HealthHealthtech
Isaac Park(CEO)inAndrew Stickney(COO)inKevin Hill(CTO)inTerrell Bacchus(CMO)in
Co-investorsFlare Capital PartnersHypothesisNew Stack VenturesPrimordial VenturesTau VenturesEverywhere Ventures+7 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.